1. Pink Sheet
  2. >>Market Access

Health Care Reform's Pricing Impact: 340B Purchasers See Initial 10% Decline in Brand Prices

 
• By Michael McCaughan

How big an impact do the new Medicaid rebate rules have on prices? There's now way to tell for sure, but prices files analyzed for the 340B program offer a pretty good clue.

Two things are clear about the changes to the Medicaid rebate program under health care reform. First, brand name manufacturers are paying a lot more in rebates than they were before enactment of the Patient Protection and Affordable Care Act in 2010. And second, it is devilishly hard for outsiders to know exactly how big an impact the changes have on any specific product or company.

Manufacturers have disclosed the overall hit to revenues from the interlocking changes to the Medicaid rebate formula, and it is...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

New Drug Procurement Rules Aim To Drive Pharma Investment In Mexico

 
• By Francesca Bruce

Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.

EU CHMP Opinions And MAA Updates

 
• By Neena Brizmohun

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

Crosstalk On Drug Pricing: Conflicts In Trump Team Rhetoric And Policy

 
• By Michael McCaughan

The Trump Administration’s rhetoric and policy approaches illustrate the confusion that often arises between efforts to cut drug prices and cutting spending.